Target intelligence / Profile preview

DNA Crosslinking (Cisplatin)

Molecular classification
DNA modification, DNA crosslinking
01

Overview

DNA crosslinking by cisplatin refers to the formation of covalent bonds between DNA bases, primarily induced by the chemotherapeutic agent cisplatin (cis-diamminedichloroplatinum(II)). This process disrupts normal DNA function and is central to cisplatin’s cytotoxic effects against cancer cells. Cisplatin enters cells and undergoes aquation, replacing its chloride ligands with water molecules. The resulting activated complex reacts with nucleophilic sites on DNA, especially at the N7 position of guanine bases. The majority of cisplatin-induced crosslinks are intrastrand, occurring between adjacent purine bases such as 1,2-GG or 1,2-AG sequences. A smaller proportion forms interstrand crosslinks or monofunctional adducts. In addition to direct DNA-DNA crosslinks, cisplatin can also induce ternary complexes involving both DNA and proteins (DNA–protein cross-links), which are more persistent and inhibit cellular repair mechanisms more effectively than simple intrastrand adducts. These lesions distort the helical structure of DNA, block replication and transcription processes, arrest cell cycle progression at S/G1/G2-M phases, and ultimately trigger apoptosis in rapidly dividing cancer cells. Cisplatin-induced bulky adducts are recognized by cellular damage response pathways. Repair is attempted mainly via nucleotide excision repair (NER) mechanisms; however, some lesions—especially interstrand or protein-linked—are difficult for cells to remove efficiently. Cisplatin’s ability to form stable intra/interstrand crosslinks underpins its effectiveness against a wide range of cancers including ovarian, lung, head/neck cancers as well as testicular and bladder tumors. Recent studies show that it can eradicate bacterial persister cells through growth-independent killing mediated by intra-strand crosslinking.

Other names
Cisplatin-induced DNA damageCisplatin DNA adductsPlatinum DNA crosslinks
02

Mechanism of action

Cisplatin enters cells and forms DNA adducts, primarily intrastrand crosslinks between guanine bases, disrupting DNA replication and transcription, leading to cell cycle arrest and apoptosis.

03

Biological functions

Cell cycle arrestApoptosis inductionDNA replication inhibitionTranscription inhibitionGrowth-independent killing (bacteria)
04

Disease associations

CancerBacterial infection
05

Safety considerations

Resistance development through increased drug efflux/export pumpsResistance development through enhanced repair capacityBulky ternary complexes resist removal
06

Interacting drugs

Cisplatin

Beyond the preview

Go deeper on DNA Crosslinking (Cisplatin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA Crosslinking (Cisplatin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call